Document Type : Case Report
Authors
Department of General Medicine, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India
Abstract
Introduction: Emamectin Benzoate (4’-deoxy-4’-epi-methyl-amino Benzoate ), widely used as a broad-spectrum insecticide has a significant human safety margin. Methemoglobinemia from toxin exposure is a rare presentation of its poisoning. Due to their easy accessibility globally, agricultural insecticides have been utilized for self-poisoning on a regular basis. However, methemoglobinemia resulting from its toxic exposure is a rare occurrence.
Case presentation: A 49-year-old farmer presented with altered mental status and difficulty in breathing 6 hours after ingesting an unknown substance which was later identified as Emamectin Benzoate at Government Stanley Medical College and Hospital, Chennai, Tamil Nadu, India, in September 2024. On admission the patient presented with hypoxemia, cyanosis and a “saturation gap”, with a co-oximetric methemoglobin level of 48%. The patient was treated with 0.1% methylene blue intravenously (IV) at a dose of 1 mg/kg body weight (total 50 mg) diluted in 50 mL of 5% dextrose over five minutes and also received 1 g intravenous vitamin C three times daily and N-acetylcysteine 1.2 gm for the methemoglobinemia. Despite the initial methylene blue treatment, his clinical status remained unchanged, so a second dose of methylene blue (50 mg) was administered an hour later. His clinical condition improved within 48 hours of treatment and was discharged on the fifth day.
Discussion: Acquired methemoglobinemia can be due to substances like local anesthetic, dapsone, amyl nitrate, quinones, sulphonamides and rarely due to insecticides. In this context, Emamectin Benzoate compound caused methemoglobinemia after ingestion.
Conclusion: Although rare, methemoglobinemia following pesticide ingestion can be fatal. It should be considered in cases of refractory hypoxemia and a "saturation gap." High clinical suspicion and appropriate management are key to improving patient outcomes.
Keywords
Main Subjects
- Godhiwala P, Nirmal A, Bakre A, Wanjari A, Kumar S. Acute Emamectin Benzoate Poisoning-A Fatal Case Report. J Evol Med Dent Sci. 2020; 9. 10.14260/jemds/2020/38.
- Price D. Methemoglobin inducers. Goldfrank’s Toxicologic Emergencies, 11th edition. 2019; 1703–1706, 1715.
- Ash-Bernal R, Wise R, Wright SM. Acquired methemoglobinemia: a retrospective series of 138 cases at 2 teaching hospitals. Medicine (Bal- timore) 2004; 83(5):265–73. DOI: 10.1097/01.md.0000141096.00377.3f
- Lolascon A, Bianchi P, Andolfo I, Russo R, Barcellini W, Fermo E, et al. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021 Dec 1;96(12):1666-78. doi: 10.1002/ajh.26340. Epub 2021 Sep 23. PMID: 34467556; PMCID: PMC9291883.
- Yen TH, Lin JL. Acute poisoning with emamectin Benzoate. J Toxicol Clin Toxicol. 2004;42(5):657-61. doi: 10.1081/clt-200026968. PMID: 15462160.
- Lalmalsawmi R, Ravikumar YS, Mahesh M, Mariyam Shihuna PM, Ramesh M, Chalasani SH. Management and prognosis of acute Emamectin Benzoate poisoning in a human. Toxicol Rep, 2024; 13:101744, ISSN 2214-7500, https://doi.org/10.1016/j.toxrep.2024.101744.
- Thuluvath SR, Das RP, Dutta N, Sarma DK. Acute Methemoglobinemia after Emamectin Benzoate Ingestion. Indian Journal of Critical Care Case Report. 2024; 3 (5): 142-44.DOI: 10.5005/jp-journals-11006-0124.
- Liang C, Cui S, Geng L. Hemoperfusion combined with methylene blue in treating methemoglobinemia caused by emamectin Benzoate + indoxacarb poisoning: A case report and literature review. Asian J Surg. 2023 Dec;46(12):5899-900. doi: 10.1016/j.asjsur.2023.08.235. Epub 2023 Sep 19. PMID: 37730503.
)